Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated comprehensive cancer center

被引：0

作者：

ElNaggar, A. C. ^{[1
]}

Liang, M. I. ^{[2
,3
]}

O'Malley, D. M. ^{[4
]}

Hade, E. M. ^{[5
]}

Copeland, L. J. ^{[4
]}

Fowler, J. M. ^{[4
]}

Salani, R. ^{[4
]}

Backes, F. J. ^{[4
]}

Cohn, D. E. ^{[4
]}

机构：

[1] Univ Tennessee, West Canc Ctr, Memphis, TN USA

[2] Univ Calif Los Angeles, Los Angeles, CA USA

[3] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[4] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA

[5] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

来源：

GYNECOLOGIC ONCOLOGY | 2017年 / 145卷

关键词：

D O I：

10.1016/j.ygyno.2017.03.353

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

325

引用

页码：152 / 153

页数：3

共 50 条

[1] Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center
ElNaggar, Adam C.
Hade, Erinn M.
O'Malley, David M.
Liang, Margaret I.
Copeland, Larry J.
Fowler, Jeffrey M.
Salani, Ritu
Backes, Floor J.
Cohn, David E.
[J]. GYNECOLOGIC ONCOLOGY, 2018, 151 (03) : 501 - 505
[2] Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center
Liang, Margaret I.
ElNaggar, Adam C.
Nekkanti, Silpa
O'Malley, David M.
Hade, Erinn M.
Copeland, Larry J.
Fowler, Jeffrey M.
Salani, Ritu
Backes, Floor J.
Cohn, David E.
[J]. GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 689 - 693
[3] Setting the bar: Compliance with ovarian cancer quality indicators at a National Cancer Institute (NCI)-designated Comprehensive Cancer Center (CCC)
Liang, M. I.
EINaggar, A. C.
Nekkanti, S.
O'Malley, D. M.
Hade, E. M.
Copeland, L. J.
Fowler, J. M.
Salani, R.
Backes, F. J.
Cohn, D. E.
[J]. GYNECOLOGIC ONCOLOGY, 2015, 137 : 41 - 42
[4] Management of Occult Primary Breast Cancer at a National Cancer Institute-Designated Comprehensive Cancer Center
Fayanju, Oluwadamilola
Jeffe, Donna
Margenthaler, Julie
[J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 40 - 40
[5] Improving the Time to Activation of New Clinical Trials at a National Cancer Institute-Designated Comprehensive Cancer Center
Williams, Erin
Brown, Timothy J.
Griffith, Patrice
Rahimi, Asal
Oilepo, Rhonda
Hammers, Hans
Laetsch, Theodore W.
Currykosky, Penny
Partridge, Susan
Beg, Muhammad S.
[J]. JCO ONCOLOGY PRACTICE, 2020, 16 (04) : 166 - +
[6] Oncologists' perspectives on concurrent palliative care in a National Cancer Institute-designated comprehensive cancer center
Bakitas, Marie
Lyons, Kathleen Doyle
Hegel, Mark T.
Ahles, Tim
[J]. PALLIATIVE & SUPPORTIVE CARE, 2013, 11 (05) : 415 - 423
[7] Cancer disparities among sexual and gender minority patients at a National Cancer Institute-Designated Comprehensive Cancer Center
Zamani, Shahrzad A.
Perez-Morales, Jaileene
Miller, Jarred D.
Schabath, Matthew B.
[J]. CANCER RESEARCH, 2023, 83 (07)
[8] Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center
Miller, Kenneth
Mehta, Rutika
Abraham, Joseph
Opneja, Aman
Jain, Rohit K.
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (06): : 639 - 643
[9] Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated Comprehensive Cancer Centers
Kupfer, Sonia S.
Lubner, Sam
Coronel, Emmanuel
Pickhardt, Perry J.
Tipping, Matthew
Graffy, Peter
Keenan, Eileen
Ross, Eric
Li, Tianyu
Weinberg, David S.
[J]. CANCER MEDICINE, 2018, 7 (11): : 5351 - 5358
[10] Incorporating a compact proton therapy unit into an existing National Cancer Institute-designated comprehensive cancer center
Mansur, David B.
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (09) : 1001 - 1005

← 1 2 3 4 5 →